ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
134 hedge funds and large institutions have $471M invested in iTeos Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 56 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 136 → 134 (-2)
4.58% less ownership
Funds ownership: 100.99% → 96.4% (-4.6%)
41% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 56
Holders
134
Holding in Top 10
2
Calls
$2.41M
Puts
$786K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$12.1M | |
| 3 | +$3.34M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$3.12M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.42M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$8.6M | |
| 3 | -$6.02M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$4.38M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.55M |